MEDIFAST Price Cash Flow Ratio vs Cash Conversion Cycle Analysis
MED Stock | USD 18.62 0.21 1.14% |
MEDIFAST INC financial indicator trend analysis is infinitely more than just investigating MEDIFAST INC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MEDIFAST INC is a good investment. Please check the relationship between MEDIFAST INC Price Cash Flow Ratio and its Cash Conversion Cycle accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
Price Cash Flow Ratio vs Cash Conversion Cycle
Price Cash Flow Ratio vs Cash Conversion Cycle Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MEDIFAST INC Price Cash Flow Ratio account and Cash Conversion Cycle. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between MEDIFAST INC's Price Cash Flow Ratio and Cash Conversion Cycle is -0.69. Overlapping area represents the amount of variation of Price Cash Flow Ratio that can explain the historical movement of Cash Conversion Cycle in the same time period over historical financial statements of MEDIFAST INC, assuming nothing else is changed. The correlation between historical values of MEDIFAST INC's Price Cash Flow Ratio and Cash Conversion Cycle is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price Cash Flow Ratio of MEDIFAST INC are associated (or correlated) with its Cash Conversion Cycle. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Conversion Cycle has no effect on the direction of Price Cash Flow Ratio i.e., MEDIFAST INC's Price Cash Flow Ratio and Cash Conversion Cycle go up and down completely randomly.
Correlation Coefficient | -0.69 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Price Cash Flow Ratio
Cash Conversion Cycle
Most indicators from MEDIFAST INC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MEDIFAST INC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.At present, MEDIFAST INC's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 6.96, whereas Tax Provision is forecasted to decline to about 26.5 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.1B | 1.1B | 775.9M | 814.6M | Total Revenue | 1.5B | 1.6B | 1.1B | 1.1B |
MEDIFAST INC fundamental ratios Correlations
Click cells to compare fundamentals
MEDIFAST INC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MEDIFAST INC fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 194.7M | 276.1M | 398.3M | 316.2M | 309.9M | 325.4M | |
Other Current Liab | 49.3M | 57.3M | 84.4M | 69.1M | 48.5M | 50.9M | |
Total Current Liabilities | 79.4M | 111.4M | 169.8M | 140.9M | 92.3M | 96.9M | |
Total Stockholder Equity | 104.8M | 157.2M | 202.5M | 155.0M | 201.5M | 211.6M | |
Property Plant And Equipment Net | 38.8M | 38.1M | 80.6M | 75.6M | 67.1M | 70.5M | |
Net Debt | (63.4M) | (152.6M) | (71.6M) | (61.6M) | (72.4M) | (68.8M) | |
Retained Earnings | 168.8M | 154.4M | 190.3M | 139.9M | 174.6M | 183.4M | |
Cash | 77.0M | 163.7M | 104.2M | 87.7M | 94.4M | 99.2M | |
Non Current Assets Total | 40.5M | 41.8M | 91.5M | 93.4M | 85.9M | 90.2M | |
Non Currrent Assets Other | 353K | 2.9M | 6.5M | 12.5M | 14.7M | 15.4M | |
Cash And Short Term Investments | 92.7M | 174.5M | 109.5M | 87.7M | 150.0M | 157.5M | |
Net Receivables | 1.0M | 1.4M | 584K | 0.0 | 8.7M | 9.2M | |
Common Stock Shares Outstanding | 12.1M | 11.9M | 11.8M | 11.3M | 10.9M | 12.2M | |
Liabilities And Stockholders Equity | 194.7M | 276.1M | 398.3M | 316.2M | 309.9M | 325.4M | |
Non Current Liabilities Total | 10.4M | 7.5M | 26.0M | 20.3M | 16.1M | 16.9M | |
Inventory | 48.8M | 53.4M | 180.0M | 118.9M | 54.6M | 27.8M | |
Other Current Assets | 11.3M | 12.3M | 17.3M | 16.2M | 19.4M | 20.4M | |
Other Stockholder Equity | (64.0M) | 2.8M | 12.0M | 15.2M | 26.6M | 27.9M | |
Total Liab | 89.8M | 118.8M | 195.9M | 161.2M | 108.4M | 113.8M | |
Property Plant And Equipment Gross | 38.8M | 38.1M | 113.3M | 115.6M | 114.4M | 120.1M | |
Total Current Assets | 154.2M | 234.3M | 306.9M | 222.8M | 224.0M | 235.2M | |
Short Term Debt | 3.2M | 7.3M | 6.5M | 5.8M | 11.8M | 12.4M | |
Accounts Payable | 22.6M | 36.1M | 70.9M | 58.7M | 39.2M | 21.4M | |
Accumulated Other Comprehensive Income | 25K | 41K | 111K | 24K | 248K | 260.4K | |
Other Assets | 1.7M | 14.1M | 10.9M | 17.8M | 20.5M | 21.5M | |
Short Term Investments | 15.7M | 10.8M | 5.4M | (23K) | 55.6M | 58.4M | |
Property Plant Equipment | 26.0M | 27.6M | 56.1M | 57.2M | 65.8M | 69.1M | |
Net Tangible Assets | 104.8M | 157.2M | 202.5M | 155.0M | 178.3M | 125.0M | |
Retained Earnings Total Equity | 168.8M | 154.4M | 190.3M | 139.9M | 160.8M | 126.9M | |
Capital Surpluse | 0.0 | 7.8M | 12.0M | 21.6M | 19.4M | 10.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share 0.67 | Revenue Per Share 61.769 | Quarterly Revenue Growth (0.41) | Return On Assets 0.0477 |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.